Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 13Gastrointestinal 4Other 2Lymphoid 2CNS 2Thoracic 1Sarcoma 1Other solid neoplasm 1Breast 1

Conditions

Waldenstrom Macroglobulinemia 1Pre-Eclampsia 1Lymphoma, Follicular 1

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Sildenafil Citrate × Lymphoid × Clear all
NCT03262961 2017-08-28

Use of Sildenafil Citrate in Management of Mild Pre-eclampsia

Assiut University

Phase 2/3 Unknown
80 enrolled
Lymphoid

Lymphoma, Follicular, Pre-Eclampsia

NCT00165295 2011-06-27

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute

Phase 2 Completed
30 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡